As of December 15, 2025, Jiangsu Bioperfectus Technologies Co Ltd (688399.SS) reports a Forward P/E of N/A.
Forward P/E gauges the price investors pay for each dollar of anticipated earnings, offering insight into a stock's future valuation.
Comparing Jiangsu Bioperfectus Technologies Co Ltd's Forward P/E to Peers
To better understand Jiangsu Bioperfectus Technologies Co Ltd's position, it's useful to compare its Forward P/E against industry peers. Below are selected comparisons:
| Company | Forward P/E |
|---|---|
| Jiangsu Bioperfectus Technologies Co Ltd (688399.SS) | - |
| Nanosonics Ltd (NAN.AX) | 63.43 |
| Sansure Biotech Inc (688289.SS) | 33.97 |
| Nanjing Vishee Medical Technology Co Ltd (688580.SS) | 31.45 |
| Eyebright Medical Technology (Beijing) Co Ltd (688050.SS) | 27.11 |
| Blue Sail Medical Co Ltd (002382.SZ) | 25.88 |
Compared to its competitors, Jiangsu Bioperfectus Technologies Co Ltd's Forward P/E is difficult to compare due to insufficient data.